Cited by 22Pharmaceutical Economics and PolicyPharmaceutical Quality and CounterfeitingBiotechnology and Related Fields

Dying from lack of medicines

Pheage, Tefo·2017·Africa Renewal

Abstract

Approximately 1.6 million Africans died of malaria, tuberculosis and HIV-related illnesses in 2015. These diseases can be prevented or treated with timely access to appropriate and affordable medicines, vaccines and other health services. But less than 2% of drugs consumed in Africa are produced on the continent, meaning that many sick patients do not have access to locally produced drugs and may not afford to buy the imported ones.

Integrity signals

Registry

Crossref · 10.18356/01fc1a55-en

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Poor procurement practices, the inability to pay for drugs and poor stability of drug products at high temperature and humidity prevent access to effective treatments.

    “Poor procurement practices, the inability to pay for drugs and poor stability of drug products at high temperature and humidity prevent access to effective treatments 5 .”

    From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [5]

Cited by

Sorted by citations

Authors
Pheage, T.
Corresponding author
Pheage, Tefo
Venue
Africa Renewal
Published
2017-03-13
Volume
30
Issue
3
Pages
24-25
ISSN
  • 1816-9627 (ISSN-L)
  • 2517-9829
OpenAlex
W2774131336
Cited by
22
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 1
FWCI
2.46
Type
journal article
Language
en
Open access
closed
Locations
Africa renewal (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Biotechnology and Related Fields
Keywords
access to medicines, pharmaceutical industry, drug affordability, malaria, tuberculosis, HIV, vaccines, imported drugs, Africa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review